At the 2026 Cell-Cell Symposium at UCLA, Partillion Bioscience highlighted its role in advancing a new era of cell-cell interaction mapping. Joe de Rutte, CEO of Partillion Bioscience, presented how ...
As cell therapy advances toward clinical reality, iPSC-derived cellular products, in vivo reprogramming strategies, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results